Thailand Moves to Recriminalise Cannabis, Shaking US$1 Billion Industry
- Thailand's government announced on Tuesday that it will classify cannabis as a narcotic again, reversing the 2022 decriminalization.
- This move follows unregulated cannabis access causing social problems, the Bhumjaithai Party leaving the ruling coalition, and foreign pressure over smuggling.
- Since decriminalization, the cannabis industry boomed with about 11,000 shops and an estimated worth of over US$1 billion, but now faces regulatory uncertainty.
- Health Minister Somsak Thepsuthin stated that cannabis regulations should revert to limiting its use strictly for medical purposes, while critics described the situation as "completely absurd" and argued that the industry is being held hostage by political disputes.
- New rules will require doctor prescriptions for cannabis sales, pending Royal Gazette publication, potentially limiting growth and aiming to restore prior drug controls.
18 Articles
18 Articles
Thailand decriminalized cannabis use three years ago, now the government wants to criminalize it again.
Thailand moves to recriminalise cannabis, shaking US$1 billion industry
BANGKOK: Thailand's government is moving to recriminalise cannabis, plunging into limbo an industry estimated to be worth over US$1 billion that has boomed since the substance was taken off the country's narcotics list in 2022. The push to impose new controls on recreational use of cannabis comes after the
Thailand moves to recriminalize cannabis, shaking $1-B industry
BANGKOK, Thailand – Thailand’s government is moving to recriminalize cannabis, plunging into limbo an industry estimated to be worth over $1 billion that has boomed since the substance was taken off the country’s narcotics list in 2022. The push to impose new controls on recreational use of cannabis comes after the Bhumjaithai Party, which championed its legalisation, withdrew from the ruling coalition last week following Thai Prime Minister Pae…
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium